These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Intrahepatic cholangiocarcinoma: Is there a role for liver transplantation? Kim P; Littau M; Baker TB; Abdelsattar Z; Tonelli C; Bunn C; Kulshrestha S; Luchette FA; Baker MS Surgery; 2022 Mar; 171(3):741-746. PubMed ID: 34895770 [TBL] [Abstract][Full Text] [Related]
32. A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients. Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Moro A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM Ann Surg Oncol; 2020 Apr; 27(4):1110-1119. PubMed ID: 31728792 [TBL] [Abstract][Full Text] [Related]
33. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533 [TBL] [Abstract][Full Text] [Related]
34. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection. Lei Z; Xia Y; Si A; Wang K; Li J; Yan Z; Yang T; Wu D; Wan X; Zhou W; Liu J; Wang H; Cong W; Wu M; Pawlik TM; Lau WY; Shen F J Hepatol; 2018 Apr; 68(4):655-662. PubMed ID: 29155069 [TBL] [Abstract][Full Text] [Related]
36. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study. Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of neutrophil distribution in cholangiocarcinoma. Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010 [TBL] [Abstract][Full Text] [Related]
38. Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features. Liu H; Lan T; Cai YS; Lyu YH; Zhu J; Xie SN; Hu FJ; Liu C; Wu H Asian J Surg; 2024 Jun; 47(6):2589-2597. PubMed ID: 38604849 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma. Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127 [TBL] [Abstract][Full Text] [Related]
40. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]